Back to results

Tavneos Liver Injury Risks, Faked Data Lead FDA To Seek Market Removal

via AboutLawsuits Published: Apr 29, 2026

Summary

Amgen has received a letter from the FDA indicating the agency plans to remove Tavneos from the market after discovering falsified data in the original clinical trial.

Read full article →